Results 131 to 140 of about 133,285 (252)

A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform. [PDF]

open access: yesJ Bacteriol, 2018
Liao J   +3 more
europepmc   +1 more source

From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy

open access: yesBMEMat, EarlyView.
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen   +9 more
wiley   +1 more source

Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain. [PDF]

open access: yesFront Microbiol, 2018
Kim MJ   +9 more
europepmc   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

open access: yesBMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim   +9 more
wiley   +1 more source

NIR-II-activated whole-cell vaccine with ultra-efficient semiconducting diradical oligomers for breast carcinoma growth and metastasis inhibition. [PDF]

open access: yesActa Pharm Sin B
Gao Y   +12 more
europepmc   +1 more source

Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine. [PDF]

open access: yesEmerg Microbes Infect, 2019
Safarchi A   +8 more
europepmc   +1 more source

Purification and concentration of model viruses using single‐pass tangential flow filtration

open access: yesBiotechnology Progress, EarlyView.
Single‐pass TFF was developed for an enveloped and non‐enveloped virus for use in continuous downstream purification processes. Enveloped virus was concentrated and purified. Abstract The vaccine and viral vector industry is growing at an accelerated rate.
Luis Alberto Mejía‐Manzano   +6 more
wiley   +1 more source

Immunogenicity and efficacy of CNA25 as a potential whole-cell vaccine against systemic candidiasis. [PDF]

open access: yesEMBO Mol Med
Sahu SR   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy